Research Article
TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer
Table 3
Expression of TMUB1 associated with clinicopathological characteristics (logistic regression).
| Characteristics | Odds ratio in TMUB1 expression | Odds ratio (OR) | value |
| T stage (T3 and T4 vs. T1 and T2) | 617 | 0.63 (0.42-0.94) | 0.023 | N stage (N1 and N2 vs. N0) | 616 | 0.93 (0.67-1.27) | 0.633 | M stage (M1 vs. M0) | 546 | 1.37 (0.87-2.20) | 0.18 | Pathologic stage (stage III and stage IV vs. stage I and stage II) | 599 | 1.00 (0.72-1.38) | 0.992 | Neoplasm type (rectum adenocarcinoma vs. colon adenocarcinoma) | 619 | 0.92 (0.65-1.32) | 0.667 | Residual tumor (R1 and R2 vs. R0) | 492 | 2.35 (1.20-4.88) | 0.016 | CEA level (>5 vs. <=5) | 397 | 0.86 (0.57-1.29) | 0.455 | TP53 status (Mut vs. WT) | 526 | 1.36 (0.96-1.93) | 0.085 | KRAS status (Mut vs. WT) | 526 | 0.95 (0.67-1.34) | 0.761 | PIK3CA status (Mut vs. WT) | 526 | 0.91 (0.62-1.36) | 0.657 |
|
|